Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1905 1
1946 1
1947 1
1948 4
1949 3
1950 2
1951 2
1952 10
1953 6
1954 2
1955 2
1957 3
1959 1
1960 3
1961 2
1964 2
1965 2
1966 2
1967 2
1968 3
1969 3
1970 3
1971 6
1972 3
1973 8
1974 3
1975 6
1976 3
1977 7
1978 5
1979 13
1980 8
1981 7
1982 10
1983 17
1984 11
1985 10
1986 12
1987 16
1988 13
1989 22
1990 9
1991 15
1992 14
1993 21
1994 12
1995 25
1996 16
1997 20
1998 13
1999 27
2000 18
2001 31
2002 19
2003 21
2004 20
2005 26
2006 28
2007 28
2008 31
2009 27
2010 38
2011 53
2012 56
2013 60
2014 59
2015 65
2016 52
2017 44
2018 65
2019 46
2020 56
2021 54
2022 45
2023 33
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

1,308 results

Results by year

Filters applied: . Clear all
Page 1
Hepatocellular carcinoma.
Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Llovet JM, et al. Among authors: kelley rk. Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3. Nat Rev Dis Primers. 2021. PMID: 33479224 Review.
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Fuster J, Ayuso C, Bruix J. Reig M, et al. Among authors: kelley rk. J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19. J Hepatol. 2022. PMID: 34801630 Free PMC article. Review.
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma.
Llovet JM, Pinyol R, Kelley RK, El-Khoueiry A, Reeves HL, Wang XW, Gores GJ, Villanueva A. Llovet JM, et al. Among authors: kelley rk. Nat Cancer. 2022 Apr;3(4):386-401. doi: 10.1038/s43018-022-00357-2. Epub 2022 Apr 28. Nat Cancer. 2022. PMID: 35484418 Free PMC article. Review.
Biliary tract cancer.
Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Valle JW, et al. Among authors: kelley rk. Lancet. 2021 Jan 30;397(10272):428-444. doi: 10.1016/S0140-6736(21)00153-7. Lancet. 2021. PMID: 33516341 Review.
Cholangiocarcinoma - evolving concepts and therapeutic strategies.
Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Rizvi S, et al. Among authors: kelley rk. Nat Rev Clin Oncol. 2018 Feb;15(2):95-111. doi: 10.1038/nrclinonc.2017.157. Epub 2017 Oct 10. Nat Rev Clin Oncol. 2018. PMID: 28994423 Free PMC article. Review.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Kelley RK, et al. Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16. Lancet. 2023. PMID: 37075781 Clinical Trial.
Emerging Concepts in Vascular Dementia: A Review.
Bir SC, Khan MW, Javalkar V, Toledo EG, Kelley RE. Bir SC, et al. Among authors: kelley re. J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105864. doi: 10.1016/j.jstrokecerebrovasdis.2021.105864. Epub 2021 May 29. J Stroke Cerebrovasc Dis. 2021. PMID: 34062312 Free article. Review.
Immunology and immunotherapy of cholangiocarcinoma.
Greten TF, Schwabe R, Bardeesy N, Ma L, Goyal L, Kelley RK, Wang XW. Greten TF, et al. Among authors: kelley rk. Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):349-365. doi: 10.1038/s41575-022-00741-4. Epub 2023 Jan 25. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36697706 Review.
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
Goyal L, Meric-Bernstam F, Hollebecque A, Valle JW, Morizane C, Karasic TB, Abrams TA, Furuse J, Kelley RK, Cassier PA, Klümpen HJ, Chang HM, Chen LT, Tabernero J, Oh DY, Mahipal A, Moehler M, Mitchell EP, Komatsu Y, Masuda K, Ahn D, Epstein RS, Halim AB, Fu Y, Salimi T, Wacheck V, He Y, Liu M, Benhadji KA, Bridgewater JA; FOENIX-CCA2 Study Investigators. Goyal L, et al. Among authors: kelley rk. N Engl J Med. 2023 Jan 19;388(3):228-239. doi: 10.1056/NEJMoa2206834. N Engl J Med. 2023. PMID: 36652354 Clinical Trial.
1,308 results